4 results
The primary objective of this study is to obtain clinical proof of principle that the addition of a PgP/BCRP inhibitor increases CNS concentrations of tyrosine kinase inhibitors by inhibition of drug efflux transporter function in the blood brain…
The primary objective for this study is as follows:Within the TP53 wild-type populationTo compare overall survival (OS) in patients with relapsed or refractory AML who havebeen randomized to idasanutlin in combination with cytarabine versus those…
The goal of this pilot study is to assess the usability and preliminary effects on treatment outcomes of an mHealth application supplementary to SET for patients with intermittent claudication. Furthermore, we aim to determine the reliability,…
Aim: To determine the specificity and sensitivity of the AF app to detect AF.